CrossrefInfokarte
QRISK3 Assessment Identified Essential Thrombocythemia Patients at High Risk of Thrombotic Events Regardless of Revised IPSET‐T Score and JAK2 Mutational Status
eJHaem · 2026-12 · 7 (6)
DOI: 10.1002/jha2.70446 ↗Abstract
Kein Abstract verfügbar.
EUVIMED